| Reference number |
2025-02493 |
| Coordinator |
Cognes Medical Solutions AB |
| Funding from Vinnova |
SEK 500 000 |
| Project duration |
November 2025 - August 2026
|
| Status |
Completed |
| Venture |
Innovative Startups |
| Call |
Innovative Startups 2025 |
Important results from the project
The project resulted in an improved AI model, app, web platform and secure data flows for research use. Cognes also developed study protocols, technical documentation and collaboration processes, and refined the call for proposals for pharmaceutical companies, CROs and research organizations.
Expected long term effects
The results may contribute to more accessible and objective prescreening in dementia research. In the longer term, the technology may facilitate earlier identification of suitable study participants, broaden participation, and streamline recruitment and follow-up in clinical trials.
Approach and implementation
The work was organized into coordinated tracks for model development, app and platform, data management, study preparation, intellectual property rights, and market analysis. Research partners and external experts continuously contributed clinical, technical, and commercial perspectives.
External links
The project description has been provided by the project members themselves and the text has not been looked at by our editors.